Depo-Provera 150mg

All potential users of DEPO-PROVERA 150mg should have a negative pregnancy test before first administration.
Because of the risk of heavy or prolonged bleeding in some women, the drug should be used with caution in the puerperium.

Each pre-filled syringe contains 1 ml of suspension containing 150 mg medroxyprogesterone acetate.

Excipients with known effect:

– Methyl parahydroxybenzoate (E218) 1.35 mg,
– Propyl parahydroxybenzoate (E216)  0.15 mg
– Sodium chloride 3.38 mg/ml

DEPO-PROVERA 150mg may also be used for short-term contraception in the following circumstances:

– For partners of men undergoing vasectomy, for protection until the vasectomy becomes effective.
– In women who are being immunised against rubella, to prevent pregnancy during the period of activity of the virus.
– In women awaiting sterilisation.